HEADER UNKNOWN FUNCTION 02-SEP-15 2N72 TITLE SOLUTION STRUCTURE OF THE Q DOMAIN FROM ACBD3 COMPND MOL_ID: 1; COMPND 2 MOLECULE: GOLGI RESIDENT PROTEIN GCP60; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 241-308; COMPND 5 SYNONYM: ACYL-COA-BINDING DOMAIN-CONTAINING PROTEIN 3, GOLGI COMPLEX- COMPND 6 ASSOCIATED PROTEIN 1, GOCAP1, GOLGI PHOSPHOPROTEIN 1, GOLPH1, PBR- COMPND 7 AND PKA-ASSOCIATED PROTEIN 7, PERIPHERAL BENZODIAZEPINE RECEPTOR- COMPND 8 ASSOCIATED PROTEIN PAP7; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ACBD3, GCP60, GOCAP1, GOLPH1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS UNKNOWN FUNCTION EXPDTA SOLUTION NMR NUMMDL 30 AUTHOR V.VEVERKA,R.HEXNEROVA REVDAT 3 15-MAY-24 2N72 1 REMARK REVDAT 2 14-JUN-23 2N72 1 REMARK SEQADV REVDAT 1 20-JUL-16 2N72 0 JRNL AUTH M.KLIMA,D.J.TOTH,R.HEXNEROVA,A.BAUMLOVA,D.CHALUPSKA, JRNL AUTH 2 J.TYKVART,L.REZABKOVA,N.SENGUPTA,P.MAN,A.DUBANKOVA, JRNL AUTH 3 J.HUMPOLICKOVA,R.NENCKA,V.VEVERKA,T.BALLA,E.BOURA JRNL TITL STRUCTURAL INSIGHTS AND IN VITRO RECONSTITUTION OF MEMBRANE JRNL TITL 2 TARGETING AND ACTIVATION OF HUMAN PI4KB BY THE ACBD3 JRNL TITL 3 PROTEIN. JRNL REF SCI REP V. 6 23641 2016 JRNL REFN ESSN 2045-2322 JRNL PMID 27009356 JRNL DOI 10.1038/SREP23641 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA, CYANA REMARK 3 AUTHORS : GUNTERT, MUMENTHALER AND WUTHRICH (CYANA), REMARK 3 GUNTERT, MUMENTHALER AND WUTHRICH (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2N72 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-SEP-15. REMARK 100 THE DEPOSITION ID IS D_1000104503. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 0.1 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.28 MM [U-13C; U-15N] PROTEIN, REMARK 210 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D HNCACB; 3D CBCA(CO)NH; 3D REMARK 210 HNCO; 3D HN(CO)CA; 2D 1H-15N REMARK 210 HSQC; 3D 1H-15N NOESY; 3D 1H-13C REMARK 210 NOESY; 3D HCCH-TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 850 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : SIMULATED ANNEALING, MOLECULAR REMARK 210 DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 30 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 4 ARG A 39 NE - CZ - NH1 ANGL. DEV. = 3.6 DEGREES REMARK 500 27 ARG A 39 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES REMARK 500 28 ARG A 39 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 3 GLN A 68 74.02 -107.87 REMARK 500 7 ALA A 16 -71.20 -48.35 REMARK 500 8 LYS A 67 21.43 -143.66 REMARK 500 9 GLN A 66 49.98 32.93 REMARK 500 9 LYS A 67 43.65 -76.80 REMARK 500 10 ALA A 16 -72.70 -47.83 REMARK 500 10 GLN A 66 38.82 39.04 REMARK 500 10 LYS A 67 39.40 -79.31 REMARK 500 11 ALA A 16 -73.53 -47.73 REMARK 500 11 TYR A 27 66.69 -119.13 REMARK 500 11 GLN A 66 37.81 35.60 REMARK 500 11 GLN A 68 52.80 -99.73 REMARK 500 12 GLN A 2 133.01 72.32 REMARK 500 12 GLN A 66 38.75 37.69 REMARK 500 13 GLN A 2 17.90 57.25 REMARK 500 13 LYS A 67 31.68 -81.41 REMARK 500 15 GLN A 3 18.03 54.88 REMARK 500 15 ALA A 16 -72.50 -53.28 REMARK 500 15 TYR A 27 69.90 -119.62 REMARK 500 15 LYS A 67 39.19 -95.37 REMARK 500 17 LYS A 4 -44.21 62.71 REMARK 500 17 ALA A 16 -70.59 -49.57 REMARK 500 17 GLN A 68 80.71 42.36 REMARK 500 18 GLN A 3 47.48 -69.19 REMARK 500 18 LYS A 67 88.25 -153.29 REMARK 500 19 ALA A 16 -70.37 -43.64 REMARK 500 20 GLN A 68 79.70 47.80 REMARK 500 21 GLN A 3 6.64 -66.91 REMARK 500 22 GLN A 2 46.54 -75.26 REMARK 500 23 LYS A 67 31.78 -77.82 REMARK 500 24 LYS A 4 -45.48 64.72 REMARK 500 24 GLN A 66 28.79 48.68 REMARK 500 25 TYR A 27 69.47 -119.45 REMARK 500 26 LYS A 4 -34.63 -150.68 REMARK 500 28 ALA A 16 -70.51 -49.84 REMARK 500 28 GLN A 66 48.57 30.26 REMARK 500 29 GLN A 66 29.96 47.40 REMARK 500 30 GLN A 66 50.13 34.47 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 25790 RELATED DB: BMRB REMARK 900 RELATED ID: 2N73 RELATED DB: PDB DBREF 2N72 A 2 69 UNP Q9H3P7 GCP60_HUMAN 241 308 SEQADV 2N72 MET A 1 UNP Q9H3P7 INITIATING METHIONINE SEQRES 1 A 69 MET GLN GLN LYS GLN GLN ILE MET ALA ALA LEU ASN SER SEQRES 2 A 69 GLN THR ALA VAL GLN PHE GLN GLN TYR ALA ALA GLN GLN SEQRES 3 A 69 TYR PRO GLY ASN TYR GLU GLN GLN GLN ILE LEU ILE ARG SEQRES 4 A 69 GLN LEU GLN GLU GLN HIS TYR GLN GLN TYR MET GLN GLN SEQRES 5 A 69 LEU TYR GLN VAL GLN LEU ALA GLN GLN GLN ALA ALA LEU SEQRES 6 A 69 GLN LYS GLN GLN HELIX 1 1 GLN A 3 TYR A 27 1 25 HELIX 2 2 ASN A 30 GLN A 66 1 37 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1